CRISPR Therapeutics
CRSP
#3206
Rank
C$5.19 B
Marketcap
$60.56
Share price
-3.45%
Change (1 day)
-39.87%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2023 (TTM): -$7.18

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -$7.64. In 2022 the company made an earnings per share (EPS) of -$12.07 a decrease over its 2021 EPS that were of $7.20.

EPS history for CRISPR Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.18-40.51%
2022-$12.07-267.74%
2021$7.20-194.33%
2020-$7.63-576.58%
2019$1.60-132.36%
2018-$4.95100.58%
2017-$2.47159.42%
2016-$0.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.14-58.87%๐Ÿ‡บ๐Ÿ‡ธ USA